929 related articles for article (PubMed ID: 12665841)
1. Extracorporeal photopheresis therapy in the management of steroid-refractory or steroid-dependent cutaneous chronic graft-versus-host disease after allogeneic stem cell transplantation: feasibility and results.
Apisarnthanarax N; Donato M; Körbling M; Couriel D; Gajewski J; Giralt S; Khouri I; Hosing C; Champlin R; Duvic M; Anderlini P
Bone Marrow Transplant; 2003 Mar; 31(6):459-65. PubMed ID: 12665841
[TBL] [Abstract][Full Text] [Related]
2. Treatment of extensive chronic graft-versus-host disease with extracorporeal photochemotherapy.
Bisaccia E; Palangio M; Gonzalez J; Adler KR; Scarborough R; Goldberg SL; Rowley SD
J Clin Apher; 2006 Oct; 21(3):181-7. PubMed ID: 16607632
[TBL] [Abstract][Full Text] [Related]
3. Extracorporeal photoimmunotherapy for the treatment of steroid refractory progressive chronic graft-versus-host disease.
Ilhan O; Arat M; Arslan O; Ayyildiz E; Sanli H; Beksac M; Ozcan M; Gürman G; Akan H
Transfus Apher Sci; 2004 Jun; 30(3):185-7. PubMed ID: 15172621
[TBL] [Abstract][Full Text] [Related]
4. Prospective study of extracorporeal photopheresis in steroid-refractory or steroid-resistant extensive chronic graft-versus-host disease: analysis of response and survival incorporating prognostic factors.
Foss FM; DiVenuti GM; Chin K; Sprague K; Grodman H; Klein A; Chan G; Stiffler K; Miller KB
Bone Marrow Transplant; 2005 Jun; 35(12):1187-93. PubMed ID: 15852025
[TBL] [Abstract][Full Text] [Related]
5. A high-dose pulse steroid regimen for controlling active chronic graft-versus-host disease.
Akpek G; Lee SM; Anders V; Vogelsang GB
Biol Blood Marrow Transplant; 2001; 7(9):495-502. PubMed ID: 11669216
[TBL] [Abstract][Full Text] [Related]
6. [Extracorporeal photopheresis in the treatment of patients with refractory chronic graft-versus-host disease after allogeneic bone marrow transplantation].
Bykova TA; Kozlov AV; Stancheva NV; Semënova EV; Kulagina II; Bondarenko SN; Vavilov VN; Morozova EV; Zubarovskaia LS; Afanas'ev BV
Ter Arkh; 2013; 85(8):60-8. PubMed ID: 24137966
[TBL] [Abstract][Full Text] [Related]
7. Extracorporeal photopheresis for steroid resistant graft versus host disease in pediatric patients: a pilot single institution report.
Berger M; Pessolano R; Albiani R; Asaftei S; Barat V; Carraro F; Biasin E; Madon E; Fagioli F
J Pediatr Hematol Oncol; 2007 Oct; 29(10):678-87. PubMed ID: 17921848
[TBL] [Abstract][Full Text] [Related]
8. The effect of extracorporeal photoimmunotherapy (ECP) on serum TNF-a level in chronic graft versus host disease (GvHD).
Ayyildiz E; Arslan O; Topçuoğlu P; Arat M; Dalva K; Soydan EA; Tol M; Ilhan O
Transfus Apher Sci; 2007 Feb; 36(1):79-85. PubMed ID: 17234454
[TBL] [Abstract][Full Text] [Related]
9. Extracorporeal photopheresis (ECP) in the treatment of chronic graft-versus-host disease (GVHD).
Child FJ; Ratnavel R; Watkins P; Samson D; Apperley J; Ball J; Taylor P; Russell-Jones R
Bone Marrow Transplant; 1999 May; 23(9):881-7. PubMed ID: 10338042
[TBL] [Abstract][Full Text] [Related]
10. Unique abnormalities of CD4(+) and CD8(+) central memory cells associated with chronic graft-versus-host disease improve after extracorporeal photopheresis.
Yamashita K; Horwitz ME; Kwatemaa A; Nomicos E; Castro K; Sokolic R; Foster SF; Garofalo M; Choi U; Ryherd M; Brown MR; Leitman SF; Wayne AS; Fowler DH; Bishop MR; Childs RW; Barrett AJ; Pavletic SZ; Malech HL
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):22-30. PubMed ID: 16399598
[TBL] [Abstract][Full Text] [Related]
11. Photopheresis in pediatric graft-versus-host disease after allogeneic marrow transplantation: clinical practice guidelines based on field experience and review of the literature.
Kanold J; Merlin E; Halle P; Paillard C; Marabelle A; Rapatel C; Evrard B; Berger C; Stephan JL; Galambrun C; Piguet C; D'Incan M; Bordigoni P; Deméocq F
Transfusion; 2007 Dec; 47(12):2276-89. PubMed ID: 17764513
[TBL] [Abstract][Full Text] [Related]
12. Role of extracorporeal photochemotherapy in patients with refractory chronic graft-versus-host disease.
Rubegni P; Cuccia A; Sbano P; Cevenini G; Carcagnì MR; D'Ascenzo G; De Aloe G; Guidi S; Guglielmelli P; Marotta G; Lauria F; Bosi A; Fimiani M
Br J Haematol; 2005 Jul; 130(2):271-5. PubMed ID: 16029456
[TBL] [Abstract][Full Text] [Related]
13. Steroid-sparing effect of extracorporeal photopheresis in the therapy of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Ussowicz M; Musiał J; Mielcarek M; Tomaszewska A; Nasiłowska-Adamska B; Kałwak K; Gorczyńska E; Mariańska B; Chybicka A
Transplant Proc; 2013 Nov; 45(9):3375-80. PubMed ID: 24182819
[TBL] [Abstract][Full Text] [Related]
14. Extracorporeal photopheresis for the treatment of steroid refractory acute GVHD.
Perfetti P; Carlier P; Strada P; Gualandi F; Occhini D; Van Lint MT; Ibatici A; Lamparelli T; Bruno B; Raiola AM; Dominietto A; Di Grazia C; Bregante S; Zia S; Ferrari GM; Stura P; Pogliani E; Bacigalupo A
Bone Marrow Transplant; 2008 Nov; 42(9):609-17. PubMed ID: 18660840
[TBL] [Abstract][Full Text] [Related]
15. Extracorporeal photochemotherapy in graft-versus-host disease: a longitudinal study on factors influencing the response and survival in pediatric patients.
Perotti C; Del Fante C; Tinelli C; Viarengo G; Scudeller L; Zecca M; Locatelli F; Salvaneschi L
Transfusion; 2010 Jun; 50(6):1359-69. PubMed ID: 20113452
[TBL] [Abstract][Full Text] [Related]
16. Extracorporeal photopheresis: a useful therapy for patients with steroid-refractory acute graft-versus-host disease but not for the prevention of the chronic form.
Rubegni P; Feci L; Poggiali S; Marotta G; D'Ascenzo G; Murdaca F; Fimiani M
Br J Dermatol; 2013 Aug; 169(2):450-7. PubMed ID: 23534380
[TBL] [Abstract][Full Text] [Related]
17. Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?
Couriel D; Hosing C; Saliba R; Shpall EJ; Andelini P; Popat U; Donato M; Champlin R
Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 2):37-40. PubMed ID: 16399600
[TBL] [Abstract][Full Text] [Related]
18. Extracorporeal photopheresis in children with graft-versus-host disease.
Chan KW
J Clin Apher; 2006 Apr; 21(1):60-4. PubMed ID: 16619229
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human soluble tumor necrosis factor receptor fusion protein as treatment for steroid refractory graft-versus-host disease following allogeneic hematopoietic stem cell transplantation.
Busca A; Locatelli F; Marmont F; Ceretto C; Falda M
Am J Hematol; 2007 Jan; 82(1):45-52. PubMed ID: 16937391
[TBL] [Abstract][Full Text] [Related]
20. Extracorporeal photochemotherapy for the treatment of chronic graft-versus-host disease: trend for a possible cell dose-related effect?
Perseghin P; Galimberti S; Balduzzi A; Bonanomi S; Baldini V; Rovelli A; Dassi M; Rambaldi A; Castagna L; Corti P; Pogliani EM; Uderzo C
Ther Apher Dial; 2007 Apr; 11(2):85-93. PubMed ID: 17381528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
